Three papers published in The Lancet Psychiatry, The Lancet, and The Lancet Oncology reveal that around three-quarters of cancer patients who have major depression are not currently receiving treatment for depression
A new study conducted by researchers from the RCSI shows that higher selenium levels are associated with decreased risk of bowel cancer, especially in women.
Invitation to modern mammography screening may reduce deaths from breast cancer by about 28 per cent, suggests a study from Norway published on bmj.com.
Patients in Ireland have been involved in a breakthrough international trial of a new cancer drug that has given researchers renewed hope in the fight against leukaemia.
This is an exciting time in the development of new agents for the management of advanced prostate cancer and the future looks bright, say Dr David Galvin and Dr Gerard McVey.
Scientists from the School of Pharmacy and Pharmaceutical Sciences at TCD have made a significant discovery of a new biomarker that could help overcome resistance to newer and more targeted anti-cancer drugs, such as Herceptin, for HER2-positive cancers.
A multi-centre study led by the Fred Hutchinson Cancer Research Center in Seattle, Washington, has found that high-dose supplementation with both the trace element selenium and vitamin E increase the risk of high-grade prostate cancer. But importantly, this risk depends upon a man’s selenium status before taking the supplements.
Researchers have found the breast cancer drug tamoxifen in samples of a widely-available bodybuilding dietary supplement.
Johns Hopkins scientists say a previously known but little-studied chemical compound targets and shuts down a common cancer process. In studies of laboratory-grown human tumour cell lines, the drug disrupted tumour cell division and prevented growth of advanced cancer cells.
Researchers at the University of Louisville School of Medicine in the USA have confirmed that using a plasma thermogram — the heat profile from a person’s blood — can serve as an indicator for the presence or absence of cervical cancer, including the stage of cancer.